Cellbion Co Ltd
KOSDAQ:308430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cellbion Co Ltd
KOSDAQ:308430
|
KR |
|
Eidai Co Ltd
TSE:7822
|
JP |
|
D
|
Dio Corp
KOSDAQ:039840
|
KR |
|
B
|
Bougainville Copper Ltd
OTC:BOCOF
|
PG |
|
Sealand Capital Galaxy Ltd
F:7KM
|
KY |
|
K
|
Killi Resources Ltd
ASX:KLI
|
AU |
|
Cognor Holding SA
LSE:0LSA
|
PL |
|
Elkem ASA
OSE:ELK
|
NO |
|
A
|
Allied Bank Ltd
KAR:ABL
|
PK |
|
K
|
Kistron Co Ltd(Gyeonggi-do)
KOSDAQ:475430
|
KR |
|
China Communications Services Corp Ltd
F:CMW
|
HK |
|
Sekar Bumi Tbk PT
IDX:SKBM
|
ID |
|
E
|
Eduspec Holdings Bhd
KLSE:EDUSPEC
|
MY |
|
Celsius Resources Ltd
ASX:CLA
|
AU |
|
O
|
Omni-Lite Industries Canada Inc
F:0TA
|
US |
Bankruptcy Probability
Cellbion Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cellbion Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Cellbion Co Ltd
KOSDAQ:308430
|
175.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cellbion Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cellbion Co Ltd has total debt of 29.3B KRW. This includes both short-term (254m KRW) and long-term (29B KRW) debt.
You can find a full breakdown on its Balance Sheet.